drugset / Trial / NCT05858957

Magnesium Sulphate and Extubation Quality

NCT05858957

Phase 4 Completed 98 enrolled Cukurova University
RandomizedParallel-groupSingle-blindPrevention

Summary

The investigators aimed to search effect of magnesium Sulfate on extubation quality scores, recovery and pain in larynx micro surgery. The patients allocated to two groups to receive magnesium sulfate 30 mg/kg in 100 ml saline infusion (maximum 2g) (Group m) or saline 100 ml (Group S) before induction of anesthesia. Anesthesia induction performed with propofol 2 mg/kg, rocuronium 0.6 mg/kg, remifentanil 0.5 µg/kg and general anesthesia maintained with total intravenous anesthesia (propofol 3-7 mg/kg, remifentanil 0.05-0.1 µg/kg/min and O2/air 30/70 mixture) to the all patients. Extubation quality scores, Extubation time, NRS scores were assessed.

Timeline

Start
2023-04-20
Primary completion
2023-07-15
Completion
2023-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 30 mg/kg Intravenous

Indications

No indication recorded.